The Washington Post reviewed differences between subcutaneous and intradermal vaccine delivery, with the latter recently approved by the FDA as a dose-sparing approach that increases monkeypox ...

The FDA announced on Tuesday that it has issued an emergency use authorization to allow healthcare providers to give the vaccine via an intradermal injection vs. the previous subcutaneous injection.

In brief, 167 participants were randomly assigned to the subcutaneous-administration group and 191 participants to the intradermal-administration group. The demographic characteristics of the ...

which showed that intradermal and traditional “subcutaneous” injections of the vaccine produced similar immune responses. All of which has left some people with lingering concerns about stigma ...

Under the EUA, Jynneos is administered as 2 doses, 4 weeks (28 days) apart by intradermal injection (each dose is 0.1mL) for individuals 18 years of age and older or by subcutaneous injection ...

Varma said the side effects associated with intradermal shots could also pose ... The method uses one-fifth of the dose given by deeper subcutaneous injections, effectively quintupling the number ...

Despite limited clinical evidence, all available data suggest that intradermal administration of JYNNEOS will be as immunogenic as subcutaneous dosing for preventing monkeypox infection and ...